A systematic review of pulse steroid therapy for alopecia areata

Journal of the American Academy of Dermatology

Volumn 74, Issue 2, 2016, Pages 372-374.e5

  Shreberk Hassidim, Rony ^a   Ramot, Yuval ^a   Gilula, Zvi ^b,c   Zlotogorski, Abraham ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID; CORTICOSTEROID;

ALOPECIA; ALOPECIA AREATA; ARTICLE; CLINICAL PROTOCOL; HUMAN; PRIORITY JOURNAL; RECURRENCE RISK; STEROID THERAPY; SYSTEMATIC REVIEW; SYSTEMIC THERAPY; TREATMENT RESPONSE; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ALOPECIA AREATA; HUMANS; TREATMENT OUTCOME;

EID: 84973408847     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2015.09.045     Document Type: Article

References (5)

1. 1 Shapiro, J., Current treatment of alopecia areata. J Investig Dermatol Symp Proc 16 (2013), S42–S44.
2. 2 Burton, J., Shuster, S., Large doses of glucocorticoid in the treatment of alopecia areata. Acta Derm Venereol 55 (1974), 493–496.
3. 3 Kar, B.R., Handa, S., Dogra, S., Kumar, B., Placebo-controlled oral pulse prednisolone therapy in alopecia areata. J Am Acad Dermatol 52 (2005), 287–290.
4. 4 Uchiyama, M., Egusa, C., Hobo, A., Irisawa, R., Yamazaki, M., Tsuboi, R., Multivariate analysis of prognostic factors in patients with rapidly progressive alopecia areata. J Am Acad Dermatol 67 (2012), 1163–1173.
5. 5 Olsen, E.A., Investigative guidelines for alopecia areata. Dermatol Ther 24 (2011), 311–319.